RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, 230-0045, Japan.
The Jackson Laboratory, Bar Harbor, ME 04609, USA.
Trends Immunol. 2020 Aug;41(8):706-720. doi: 10.1016/j.it.2020.06.004. Epub 2020 Jul 3.
Rodent models for human diseases contribute significantly to understanding human physiology and pathophysiology. However, given the accelerating pace of drug development, there is a crucial need for in vivo preclinical models of human biology and pathology. The humanized mouse is one tool to bridge the gap between traditional animal models and the clinic. The development of immunodeficient mouse strains with high-level engraftment of normal and diseased human immune/hematopoietic cells has made in vivo functional characterization possible. As a patient-derived xenograft (PDX) model, humanized mice functionally correlate putative mechanisms with in vivo behavior and help to reveal pathogenic mechanisms. Combined with single-cell genomics, humanized mice can facilitate functional precision medicine such as risk stratification and individually optimized therapeutic approaches.
啮齿类动物疾病模型在理解人类生理学和病理生理学方面具有重要意义。然而,鉴于药物开发的步伐正在加快,非常需要具有人类生物学和病理学的体内临床前模型。人源化小鼠是弥合传统动物模型与临床之间差距的一种工具。具有高水平正常和患病人类免疫/造血细胞植入的免疫缺陷小鼠品系的开发使得体内功能特征成为可能。作为一种患者来源的异种移植(PDX)模型,人源化小鼠将推测的机制与体内行为相关联,并有助于揭示发病机制。结合单细胞基因组学,人源化小鼠可以促进功能精准医学,例如风险分层和个体化优化的治疗方法。